Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Pre ACTRIMS-ECTRIMS 2020 Live Virtual Course on Multiple Sclerosis

Pre ACTRIMS-ECTRIMS 2020 Live Virtual Course on Multiple Sclerosis
  • Neurology
  • Multiple sclerosis
Online Conference
Wednesday, Sep 9 - Thursday, Sep 10 2020
Washington, United States





Event format



EXCEMED, in collaboration with the European Charcot Foundation (ECF) and AcademicCME, is planning a Virtual Course to be held prior to ECTRIMS-ACTRIMS Congress.


This live, Online Programme will take place from 8am to 11.30am (EST), on both 9th & 10th September, 2020. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.

As the ACTRIMS-ECTRIMS Congress is going Virtual, we are converting the course into a Distance Learning Interactive Programme.

Even more in these circumstances, EXCEMED wants to keep its tradition of high value education and strongly believes that keeping in touch with experts and learners is the basis of ongoing growth and innovation.

The Foundation aims to keep its tradition of Pre-ECTRIMS Educational activities and, even more so, in 2020. Thanks to the partnership with the ECF and Academic CME, plans to offer remote attendees a deeper and more comprehensive learning experience in this field, has been made possible.

This is intended to be a multi-sponsor educational project, supported by a number of companies active in the neurodegenerative diseases/MS field.

Increasing knowledge on the pathogenesis of Multiple Sclerosis (MS) has led to the development of new treatment strategies and novel prognostic biomarkers. Progressive MS, which has always been considered an ‘orphan’ disease, is starting to be treated with disease modifying therapies; neuroprotective and remyelinating strategies are under investigation with the aim of promoting and preserving neuronal health. New measures suitable to establish the true effectiveness of these new therapeutic approaches are required and are currently tested in clinical trials. This course aims to provide updated scientific insights on the world of contemporary MS.


Learning objectives

The virtual course aims to achieve the following learning objectives:

  • Describe new pathogenetic mechanisms involved in MS and NMOS development

  • Illustrate mechanisms of action and safety profile of new MS treatments

  • Debate promising novel approaches to quantify MS activity

Accreditation details

Joint Accreditation Standards for Commercial Support

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement

AcademicCME designates this live material for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Virtual Live-Streamed Pre-ACTRIMS/ECTRIMS 2020 Multiple Sclerosis Curriculum has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 7 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Scientific programme

Wednesday, September 9th, 2020


Virtual Module I

8:00 am – 8:20 am       How Genes and Environment Interact to Cause MS

Alberto Ascherio, MD


8:20 am – 8:40 am       NMOSD

Kazuo Fujihara, MD


8:40 am – 9:00 am       OCT and Neurofilaments in Clinical Practice

Peter Calabresi, MD


9:00 am – 9:30 am       Faculty Discussion Q & A


9:30 am – 9:50 am       Standard MRI to Monitor Disease Courses and Treatment Response

Douglas L. Arnold, MD


9:50 am – 10:10 am      Advanced MRI to Monitor Disease Courses and Treatment Response

Nicola De Stefano


10:10 am – 10:30 am    The Spectrum of Treatments in RMS

Giancarlo Comi, MD, PhD


10:30 am – 10:50 am    Enhancing Remyelination: From Basic Studies to Interventions

Hans-Peter Hartung, MD, PhD


10.50 am -11.10 am     New Perspectives in Neurorehabilitation

Letizia Leocani, MD, PhD


11.10 am – 11:30 am    Faculty Discussion Q & A and Conclusion


Thursday, September 10th, 2020


Virtual Module II

8:00 am – 8:20 am       Understanding Progressive MS

Fred D. Lublin, MD


8:20 am – 8:40 am       Treatment Decisions in PMS

Per Soelberg Sorensen, MD


8:40 am – 9:00 am        Neuroprotective Treatments

Giancarlo Comi, MD, PhD


9:00 am – 9:30 am       Faculty Discussion Q & A


9:30 am – 9:50 am       Are We Any Closer to Understanding the Cause of MS?

Peter Calabresi, MD


9:50 am – 10:10 am      Electronic Data Capture/Devices - Can We Quantitate Disease Activity?

Jeffrey Cohen, MD


10:10 am – 10:30 am    Is it Time to Consider Combination/Add-On Therapies?

Fred D. Lublin, MD


10:30 am – 10:50 am    Are We Paying Enough Attention to Safety?

Hans-Peter Hartung, MD, PhD


10:50 am – 11:30 am    Faculty Discussion Q & A and Conclusion



Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States

Alberto Ascherio

Professor of Epidemiology and Nutrition; Professor of Medicine
Department of Epidemology and Nutrition
Harvard T.H. Chan School of Public Health
655 Huntington Avenue
Building II 3rd Floor
Boston, Massachusetts, 02115, United States

Hans Peter Hartung

Director of the Center for Neuropsychiatry and Chair of the Department of Neurology
Department of Neurology
Heinrich-Heine-University Duesseldorf
Dusseldorf, Germany

Letizia Leocani

Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy

Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States

Kazuo Fujihara

Department of Multiple Sclerosis Therapeutics
Fukushima Medical University School of Medicine

Nicola De Stefano

Department of Medicine, Surgery & Neuroscience
University of Siena
Siena, Italy
Kazuo Fujihara